A National Registry For Pulmonary Alveolar Proteinosis | MicrobiomeTrials← Back to trialsNCT02461615
A National Registry For Pulmonary Alveolar Proteinosis
RecruitingOBSERVATIONAL
Trial Details
Start: 2015-04Est. Completion: 2030-12
Enrollment target: 500 participants Locations- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Other microbiome trials you might be interested in
Pulmonary Alveolar Proteinosis (PAP)Severe Mucocutaneous Candidiasis
Background:
* Healthy people have white blood cells that protect them against bacteria, viruses, and fungi. However, so…
Bethesda, United StatesCompleted May 6, 2021
Autoimmune Pulmonary Alveolar Proteinosis
160 subjects with autoimmune pulmonary alveolar proteinosis (aPAP) will be randomized to receive once daily treatment wi…
Little Rock, United StatesEst. completion Nov 30, 2023
Autoimmune Pulmonary Alveolar Proteinosis
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disorder in which a material called surfactant builds up in t…
Los Angeles, United States